How to Invest in Stocks: Strategies for Beginning and Advanced Investors

Joel Anderson  |

How to invest? It’s a question so broad there couldn’t possibly be a single answer to it (and beware of anyone who would tell you otherwise). The reality is that there’s a number of different approaches, each of which could bring success or failure depending on when and how they’re applied.

However, anyone interested in becoming a self-directed investor should take a look at Equities.com’s resources on investing basics. We outline a number of different theories and approaches that were compiled by legendary investors, mathematicians, and financial professionals over the course of the last century.

None represent a silver bullet, but knowing and understanding these strategies can help anyone mold their own system for investing that best suits their portfolio, its needs, and its limitations.

How to Invest: Basics

How to Invest: Next-Level Strategies

o And be sure to visit our EVA (Equities Valuation Analysis) Reports research section where you can run your own DuPont Reports on any stock

Quotes from the Best

Beating the Best Mutual Funds

Equities.com’s research analyst Nicholas Bhandari breaks down his methodology for improving your returns by reducing expenses. He explains how one can mimic the returns of the most-popular mutual funds using a basket of similar ETFs that ultimately charge a much-lower expense ratio than their mutual fund counterparts.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

World Economic Forum at Davos 2019 - Frank Ricotta CEO BurstIQ

Matt Bird sits down with Frank Ricotta, CEO BurstIQ, at the World Economic Forum at Davos 2019

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.